Home › Breast Cancer › NCT05654246
Susan G. Komen's ShareForCures
ShareForCures: Susan G. Komen's People-powered, Data-driven Breast Cancer Research Registry
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Individuals must be at least 18 years old. (Individuals in Alabama and Nebraska must be over 19 and individuals in Mississippi and Pennsylvania must be over 21 to participate). * Individuals must have been diagnosed with cancer originating (or is suspected to originate) from the breast. * Individuals must be currently residing in the United States or a territory of the United States. * Individuals must be able to read and understand English. Exclusion Criteria: * Individuals under the age of 18 years. (Individuals in Alabama and Nebraska under 19 and individuals in Mississippi and Pennsylvania under 21 are not eligible to participate). * Individuals without a diagnosis of breast cancer. * Individuals who are not residing in the United States or a territory of the United States. * Individuals unable to read and understand English.
About the study
ShareForCures (SFC) is a community-based participatory research registry, and its prime objective is to engage participants representative of the United States breast cancer patient population -including minoritized and historically marginalized people, persons, or communities-to ensure the data researchers use to study breast cancer is as diverse as the people touched by this disease. In doing so, researchers will have a better understanding of breast cancer, and everyone can potentially benefit from scientific advances and improvements in care.
Sponsor: Susan G. Komen Breast Cancer Foundation · Participants: 200,000 · Started: Nov 17, 2022
Contact the study team
- Jerome Jourquin, Ph.D., M.S. · Phone: 1-877-465-6636
Official record on ClinicalTrials.gov — NCT05654246
Locations in the U.S.
| Texas | Susan G. Komen, Dallas |
Conditions
From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.